Status:
UNKNOWN
Intermittent Fasting in Nonalcoholic Fatty Liver Disease
Lead Sponsor:
Shaoguan University
Collaborating Sponsors:
Guangdong Medical University
Sun Yat-sen University
Conditions:
Intermittent Fasting
Non-Alcoholic Fatty Liver Disease
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
Although preliminary evidence suggests that intermittent fasting mimic-diet (IFD) exerts stronger effects on body weight and metabolic parameters, which may link obesity, non-alcoholic fatty liver dis...
Eligibility Criteria
Inclusion
- The diagnosed criteria of fatty liver by ultrasound were presence of two of the three following criteria: increased hepatic echogenicity compared with cortical of the right kidney, blurring of liver vasculature, and deep attenuation of the ultrasonographic signal.
Exclusion
- Excessive alcohol consumption (ethanol \> 140 g/wk for men and \> 70 g/wk for women), cirrhosis, viral hepatitis, cardiovascular disease, cancer, any consumption of nonsteroidal anti-inflammatory drugs, corticosteroids or prescriptive medicine that affect liver function, lipid and glucose metabolism.
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 31 2020
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04355910
Start Date
January 1 2018
End Date
August 31 2020
Last Update
April 21 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Guangdong Medical University
Dongguan, Guangdong, China, 523808